Dr. Shafagati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2019 - 2022
- Howard University College of MedicineClass of 2019
Certifications & Licensure
- MA State Medical License 2019 - 2022
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Loncastuximab in high-risk and heavily pretreated relapsed / refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers.Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha
Haematologica. 2024-11-14 - Antibody-Based Therapies for Peripheral T-Cell Lymphoma.Nazila Shafagati, Suman Paul, Sima Rozati, Cole H Sterling
Cancers. 2024-10-15 - 2 citationsComparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis.Nazila Shafagati, Min J Koh, Leora Boussi, Hyun J Park, Robert Stuver
Blood Advances. 2022-08-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: